4d
GlobalData on MSNFDA grants fast track status to Rznomics’ RZ-001 for HCCThe US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of ...
US FDA grants fast track designation to Rznomics’ gene therapy-based cancer drug candidate, RZ-001
US FDA grants fast track designation to Rznomics’ gene therapy-based cancer drug candidate, RZ-001: Seongnam, South Korea Wednesday, February 19, 2025, 16:00 Hrs [IST] Rznomics, ...
Anticancer drug utilizing Trans-splicing Ribozyme technology Second Fast Track Designation following brain cancer approval SEONGNAM, South Korea, Feb. 18, 2025 /PRNewswire/ -- Rznomics announced ...
The US Food and Drug Administration (FDA) has granted fast track designation to Rznomics' RZ-001 for the treatment of hepatocellular carcinoma (HCC), a form of liver cancer. This is the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results